Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B

BACKGROUND/AIMS: Tenofovir disoproxil fumarate (TDF) exhibits similar antiviral efficacy against treatment-naïve and lamivudine (LAM)-resistant chronic hepatitis B (CHB). However, there are few clinical reports on the antiviral effects of TDF–LAM combination therapy compared to TDF monotherapy in pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Mol Hepatol
Main Authors: Park, Chan Ho, Jung, Seok Won, Shin, Jung Woo, Bae, Mi Ae, Lee, Yoon Im, Park, Yong Tae, Chung, Hwa Sik, Park, Neung Hwa
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Association for the Study of the Liver 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4825170/
https://ncbi.nlm.nih.gov/pubmed/27044766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.22.1.152
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados